Red cell transufion in veno-arterial membrane oxygenation (VA ECMO) has been widely debated.
Purpose
This narrative review aims to examine the historical and current approaches of red cell transfusion in veno-arterial extracorporeal membrane oxygenation (VA ECMO) to enhance oxygen delivery. It will explore the potential benefits and pitfalls of red blood cell (RBC) transfusion in VA ECMO, including relationship between haemoglobin (Hb) concentration, tissue oxygenation and patient outcomes associated with transfusion. Following it will review the impact of cardiogenic shock on the microcirculation, performance of transfused RBC and effects of the ECMO circuit on RBC function. It will conclude with an introduction to potential mechanisms by which we might manipulate red cells to improve tissue oxygenation, without augmentation of Hb concentration.
Conclusion
Further research is needed to provide insight into optimal RBC transfusion thresholds and strategies to augment red cell function to optimise tissue oxygenation in VA ECMO.
AbbascianoRGYusuffHVlaarAPJ, et al.Blood transfusion threshold in patients receiving extracorporeal membrane oxygenation support for cardiac and respiratory failure-A systematic review and meta-analysis. J Cardiothorac Vasc Anesth2021; 35: 1192–1202. DOI: 10.1053/j.jvca.2020.08.068.
3.
NgPYChanHCVIpA, et al.Restrictive and liberal transfusion strategies in extracorporeal membrane oxygenation: a retrospective observational study. Transfusion2023; 63: 294–304. DOI: 10.1111/trf.17221.
4.
TenureRKieferJJAugoustidesJG. Blood transfusion in extracorporeal membrane oxygenation-defining thresholds and unresolved questions. J Cardiothorac Vasc Anesth2021; 35: 1203–1204. DOI: 10.1053/j.jvca.2020.11.019.
5.
ZhangYXuZHuangY, et al.Restrictive vs. Liberal red blood cell transfusion strategy in patients with acute myocardial infarction and anemia: a systematic review and meta-analysis. Front Cardiovasc Med2021; 8: 736163. DOI: 10.3389/fcvm.2021.736163.
6.
SawyerAAWiseLGhoshS, et al.Comparison of transfusion thresholds during neonatal extracorporeal membrane oxygenation. Transfusion2017; 57: 2115–2120. DOI: 10.1111/trf.14151.
7.
JenqCCTsaiFCTsaiTY, et al.Effect of anemia on prognosis in patients on extracorporeal membrane oxygenation. Artif Organs2018; 42: 705–713. DOI: 10.1111/aor.13123.
8.
AppeltHPhilippAMuellerT, et al.Factors associated with hemolysis during extracorporeal membrane oxygenation (ECMO)-Comparison of VA- versus VV ECMO. PLoS One2020; 15: e0227793. DOI: 10.1371/journal.pone.0227793.
9.
ChenFTChenSWWuVC, et al.Impact of massive blood transfusion during adult extracorporeal membrane oxygenation support on long-term outcomes: a nationwide cohort study in Taiwan. BMJ Open2020; 10: e035486. DOI: 10.1136/bmjopen-2019-035486.
10.
ChoiMHAlvarezNHTillBM, et al.Red blood cell transfusion requirements for patients on extracorporeal membrane oxygenation. Perfusion2022; 37: 377–384. DOI: 10.1177/0267659121998944.
11.
GancarJLShieldsMCWiseL, et al.Red blood cell volume, but not platelet or plasma volume is associated with mortality in neonatal ECMO. Transfusion2022; 62: 2254–2261. DOI: 10.1111/trf.17097.
12.
SurtiJJainIMishraA, et al.Venoarterial extra corporeal membrane oxygenation and blood component usage in pediatric patients undergoing cardiac surgery: single centre experience. Ann Card Anaesth2021; 24: 203–208. DOI: 10.4103/aca.ACA_112_19.
13.
McCloskeyCGEngorenMC. Transfusion and its association with mortality in patients receiving veno-arterial extracorporeal membrane oxygenation. J Crit Care2022; 68: 42–47. DOI: 10.1016/j.jcrc.2021.11.012.
14.
MuszynskiJAReederRWHallMW, et al.RBC transfusion practice in pediatric extracorporeal membrane oxygenation support. Crit Care Med2018; 46: e552–e559. DOI: 10.1097/CCM.0000000000003086.
15.
LiYWangJLiC, et al.Prognostic of red blood cell transfusion during extracorporeal membrane oxygenation therapy on mortality: a meta-analysis. Perfusion2023: 2676591231157234. DOI: 10.1177/02676591231157234.
16.
GuimbretiereGAnselmiARoisneA, et al.Prognostic impact of blood product transfusion in VA and VV ECMO. Perfusion2019; 34: 246–253. DOI: 10.1177/0267659118814690.
17.
HillersonDWhitesideHLDuganAJ, et al.Predicting mortality in nonsurgical patients before cannulation for veno-arterial extracorporeal life support: development and validation of the LACT-8 score. Cathet Cardiovasc Interv2022; 99: 1115–1124. DOI: 10.1002/ccd.30106.
18.
CushingMMKelleyJKlapperE, et al.Critical developments of 2017: a review of the literature from selected topics in transfusion. A committee report from the AABB Clinical Transfusion Medicine Committee. Transfusion2018; 58: 1065–1075. DOI: 10.1111/trf.14520.
19.
YoshidaTPrudentMD'AlessandroA. Red blood cell storage lesion: causes and potential clinical consequences. Blood Transfus2019; 17: 27–52. DOI: 10.2450/2019.0217-18.
20.
Kim-ShapiroDBLeeJGladwinMT. Storage lesion: role of red blood cell breakdown. Transfusion2011; 51: 844–851. DOI: 10.1111/j.1537-2995.2011.03100.x.
21.
Lansink-HartgringAOHoffmannRvan den BerghW, et al.Changes in red blood cell properties and platelet function during extracorporeal membrane oxygenation. J Clin Med2020; 9. DOI: 10.3390/jcm9041168.
22.
PanYLiYLiY, et al.Fatigue of red blood cells under periodic squeezes in ECMO. Proc Natl Acad Sci U S A2022; 119: e2210819119. DOI: 10.1073/pnas.2210819119.
23.
ChandlerWL. Platelet, red cell, and endothelial activation and injury during extracorporeal membrane oxygenation. Am Soc Artif Intern Organs J2021; 67: 935–942. DOI: 10.1097/MAT.0000000000001320.
24.
McMahonTJAhearnGSMoyaMP, et al.A nitric oxide processing defect of red blood cells created by hypoxia: deficiency of S-nitrosohemoglobin in pulmonary hypertension. Proc Natl Acad Sci U S A2005; 102: 14801–14806. DOI: 10.1073/pnas.0506957102.
GuttermanDDChabowskiDSKadlecAO, et al.The human microcirculation: regulation of flow and beyond. Circ Res2016; 118: 157–172. DOI: 10.1161/CIRCRESAHA.115.305364.
27.
EllisCGJaggerJSharpeM. The microcirculation as a functional system. Crit Care2005; 9(Suppl 4): S3–S8. DOI: 10.1186/cc3751.
28.
PremontRTReynoldsJDZhangR, et al.Role of nitric oxide carried by hemoglobin in cardiovascular physiology: developments on a three-gas respiratory cycle. Circ Res2020; 126: 129–158. DOI: 10.1161/CIRCRESAHA.119.315626.
RoyTKSecombTW. Effects of impaired microvascular flow regulation on metabolism-perfusion matching and organ function. Microcirculation2021; 28: e12673. DOI: 10.1111/micc.12673.
31.
PriesARSecombTW. Rheology of the microcirculation. Clin Hemorheol Microcirc2003; 29: 143–148.
32.
PriesARSecombTWGaehtgensP, et al.Blood flow in microvascular networks. Experiments and simulation. Circ Res1990; 67: 826–834. DOI: 10.1161/01.res.67.4.826.
33.
FarinaAFasanoARossoF. A theoretical model for the Fahraeus effect in medium-large microvessels. J Theor Biol2023; 558: 111355. DOI: 10.1016/j.jtbi.2022.111355.
34.
BarbeeJHCokeletGR. The Fahraeus effect. Microvasc Res1971; 3: 6–16. DOI: 10.1016/0026-2862(71)90002-1.
35.
AscoleseMFarinaAFasanoA. The Fahraeus-Lindqvist effect in small blood vessels: how does it help the heart?J Biol Phys2019; 45: 379–394. DOI: 10.1007/s10867-019-09534-4.
36.
GrackaMLimaRMirandaJM, et al.Red blood cells tracking and cell-free layer formation in a microchannel with hyperbolic contraction: a CFD model validation. Comput Methods Progr Biomed2022; 226: 107117. DOI: 10.1016/j.cmpb.2022.107117.
37.
EllisCGBatemanRMSharpeMD, et al.Effect of a maldistribution of microvascular blood flow on capillary O(2) extraction in sepsis. Am J Physiol Heart Circ Physiol2002; 282: H156–164. DOI: 10.1152/ajpheart.2002.282.1.H156.
38.
IsbellTSGladwinMTPatelRP. Hemoglobin oxygen fractional saturation regulates nitrite-dependent vasodilation of aortic ring bioassays. Am J Physiol Heart Circ Physiol2007; 293: H2565–2572. DOI: 10.1152/ajpheart.00759.2007.
39.
StamlerJS. S-nitrosothiols in the blood: roles, amounts, and methods of analysis. Circ Res2004; 94: 414–417. DOI: 10.1161/01.RES.0000122071.55721.BC.
40.
LobyshevaIIBillerPGallezB, et al.Nitrosylated hemoglobin levels in human venous erythrocytes correlate with vascular endothelial function measured by digital reactive hyperemia. PLoS One2013; 8: e76457. DOI: 10.1371/journal.pone.0076457.
41.
KleinbongardPSchulzRRassafT, et al.Red blood cells express a functional endothelial nitric oxide synthase. Blood2006; 107: 2943–2951. DOI: 10.1182/blood-2005-10-3992.
42.
CainSMCurtisSE. Experimental models of pathologic oxygen supply dependency. Crit Care Med1991; 19: 603–612. DOI: 10.1097/00003246-199105000-00006.
43.
CuinetJGarbagnatiARuscaM, et al.Cardiogenic shock elicits acute inflammation, delayed eosinophilia, and depletion of immune cells in most severe cases. Sci Rep2020; 10: 7639. DOI: 10.1038/s41598-020-64702-0.
44.
LimHS. Cardiogenic shock: failure of oxygen delivery and oxygen utilization. Clin Cardiol2016; 39: 477–483. DOI: 10.1002/clc.22564.
45.
van DiepenSKatzJNAlbertNM, et al.Contemporary management of cardiogenic shock: a scientific statement from the American heart association. Circulation2017; 136: e232–e268. DOI: 10.1161/CIR.0000000000000525.
46.
ShpektorA. Cardiogenic shock: the role of inflammation. Acute Card Care2010; 12: 115–118. DOI: 10.3109/17482941.2010.523705.
47.
KohsakaSMenonVLoweAM, et al.Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med2005; 165: 1643–1650. DOI: 10.1001/archinte.165.14.1643.
48.
VellingaNAInceCBoermaEC. Elevated central venous pressure is associated with impairment of microcirculatory blood flow in sepsis: a hypothesis generating post hoc analysis. BMC Anesthesiol2013; 13: 17. DOI: 10.1186/1471-2253-13-17.
49.
GovenderKJaniVPCabralesP. The disconnect between extracorporeal circulation and the microcirculation: a review. Am Soc Artif Intern Organs J2022; 68: 881–889. DOI: 10.1097/MAT.0000000000001618.
50.
ChommelouxJMonteroSFranchineauG, et al.Microcirculation evolution in patients on venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med2020; 48: e9–e17. DOI: 10.1097/CCM.0000000000004072.
51.
De BackerDCreteurJDuboisMJ, et al.Microvascular alterations in patients with acute severe heart failure and cardiogenic shock. Am Heart J2004; 147: 91–99. DOI: 10.1016/j.ahj.2003.07.006.
52.
Al-FaresAPettenuzzoTDel SorboL. Extracorporeal life support and systemic inflammation. Intensive Care Med Exp2019; 7: 46. DOI: 10.1186/s40635-019-0249-y.
53.
JentzerJCLawlerPRvan DiepenS, et al.Systemic inflammatory response syndrome is associated with increased mortality across the spectrum of shock severity in cardiac intensive care patients. Circ Cardiovasc Qual Outcomes2020; 13: e006956. DOI: 10.1161/CIRCOUTCOMES.120.006956.
54.
MerdjiHLevyBJungC, et al.Microcirculatory dysfunction in cardiogenic shock. Ann Intensive Care2023; 13: 38. DOI: 10.1186/s13613-023-01130-z.
55.
GovenderKCabralesP. Extracorporeal circulation impairs microcirculation perfusion and organ function. J Appl Physiol1985; 132: 794–810. DOI: 10.1152/japplphysiol.00726.2021.
56.
MillarJEFanningJPMcDonaldCI, et al.The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology. Crit Care2016; 20: 387. DOI: 10.1186/s13054-016-1570-4.
57.
RaffaeliGGhirardelloSPasseraS, et al.Oxidative stress and neonatal respiratory extracorporeal membrane oxygenation. Front Physiol2018; 9: 1739. DOI: 10.3389/fphys.2018.01739.
58.
McIRBTimpaJGKurundkarAR, et al.Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine. Lab Invest2010; 90: 128–139. DOI: 10.1038/labinvest.2009.119.
59.
DaltonHJCashenKReederRW, et al.Hemolysis during pediatric extracorporeal membrane oxygenation: associations with circuitry, complications, and mortality. Pediatr Crit Care Med2018; 19: 1067–1076. DOI: 10.1097/PCC.0000000000001709.
60.
LouSMacLarenGBestD, et al.Hemolysis in pediatric patients receiving centrifugal-pump extracorporeal membrane oxygenation: prevalence, risk factors, and outcomes. Crit Care Med2014; 42: 1213–1220. DOI: 10.1097/CCM.0000000000000128.
61.
DufourNRadjouAThuongM. Hemolysis and plasma free hemoglobin during extracorporeal membrane oxygenation support: from clinical implications to laboratory details. Am Soc Artif Intern Organs J2020; 66: 239–246. DOI: 10.1097/MAT.0000000000000974.
62.
OmarHRMirsaeidiMSociasS, et al.Plasma free hemoglobin is an independent predictor of mortality among patients on extracorporeal membrane oxygenation support. PLoS One2015; 10: e0124034. DOI: 10.1371/journal.pone.0124034.
63.
SulkowskiJPCooperJNPearsonEG, et al.Hemolysis-associated nitric oxide dysregulation during extracorporeal membrane oxygenation. J Extra Corpor Technol2014; 46: 217–223.
64.
BallaGJacobHSEatonJW, et al.Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler Thromb1991; 11: 1700–1711. DOI: 10.1161/01.atv.11.6.1700.
65.
JeneyVBallaJYachieA, et al.Pro-oxidant and cytotoxic effects of circulating heme. Blood2002; 100: 879–887. DOI: 10.1182/blood.v100.3.879.
66.
ShankaranHAlexandridisPNeelameghamS. Aspects of hydrodynamic shear regulating shear-induced platelet activation and self-association of von Willebrand factor in suspension. Blood2003; 101: 2637–2645. DOI: 10.1182/blood-2002-05-1550.
67.
ValladolidCYeeACruzMA. von Willebrand factor, free hemoglobin and thrombosis in ECMO. Front Med2018; 5: 228. DOI: 10.3389/fmed.2018.00228.
68.
SunWWangSChenZ, et al.Impact of high mechanical shear stress and oxygenator membrane surface on blood damage relevant to thrombosis and bleeding in a pediatric ECMO circuit. Artif Organs2020; 44: 717–726. DOI: 10.1111/aor.13646.
69.
HiltyMPGuerciPInceY, et al.MicroTools enables automated quantification of capillary density and red blood cell velocity in handheld vital microscopy. Commun Biol2019; 2: 217. DOI: 10.1038/s42003-019-0473-8.
70.
YehYCLeeCTWangCH, et al.Investigation of microcirculation in patients with venoarterial extracorporeal membrane oxygenation life support. Crit Care2018; 22: 200. DOI: 10.1186/s13054-018-2081-2.
71.
KaraAAkinSDos Reis MirandaD, et al.Microcirculatory assessment of patients under VA-ECMO. Crit Care2016; 20: 344. DOI: 10.1186/s13054-016-1519-7.
72.
WesterTAwanZAKverneboTS, et al.Skin microvascular morphology and hemodynamics during treatment with veno-arterial extra-corporeal membrane oxygenation. Clin Hemorheol Microcirc2014; 56: 119–131. DOI: 10.3233/CH-131670.
73.
HebertPCWellsGBlajchmanMA, et al.A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med1999; 340: 409–417. DOI: 10.1056/NEJM199902113400601.
74.
CarsonJLStanworthSJDennisJA, et al.Transfusion thresholds for guiding red blood cell transfusion. Cochrane Database Syst Rev2021; 12: CD002042. DOI: 10.1002/14651858.CD002042.pub5.
75.
MartucciGGrasselliGTanakaK, et al.Hemoglobin trigger and approach to red blood cell transfusions during veno-venous extracorporeal membrane oxygenation: the international TRAIN-ECMO survey. Perfusion2019; 34: 39–48. DOI: 10.1177/0267659119830526.
76.
OzmentCPScottBLBembeaMM, et al.Anticoagulation and transfusion management during neonatal and pediatric extracorporeal membrane oxygenation: a survey of medical directors in the United States. Pediatr Crit Care Med2021; 22: 530–541. DOI: 10.1097/PCC.0000000000002696.
77.
de BruinSScheerenTWLBakkerJ, et al.Transfusion practice in the non-bleeding critically ill: an international online survey-the TRACE survey. Crit Care2019; 23: 309. DOI: 10.1186/s13054-019-2591-6.
78.
de BruinSEggermontDvan BruggenR, et al.Transfusion practice in the bleeding critically ill: an international online survey-The TRACE-2 survey. Transfusion2022; 62: 324–335. DOI: 10.1111/trf.16789.
79.
BroganTLequierLLorrusoR, et al. Extracorporeal life support. The ELSO red Book. 5th ed.Ann Arbor: United States of America: Extracorporeal Life Support Organisation, 2017.
80.
McMichaelABVRyersonLMRatanoD, et al.2021 ELSO adult and pediatric anticoagulation guidelines. Am Soc Artif Intern Organs J2022; 68: 303–310. DOI: 10.1097/MAT.0000000000001652.
81.
MaclarenGBrodieDLorussoR, et al. Extracorporeal life support: The ELSO Red Book. 6th ed. Ann Arbor: United States of America: Extracorporeal Life Support Organisation, 2022.
82.
BembeaMMCheifetzIMFortenberryJD, et al.Recommendations on the indications for RBC transfusion for the critically ill child receiving support from extracorporeal membrane oxygenation, ventricular assist, and renal replacement therapy devices from the pediatric critical care transfusion and anemia Expertise initiative. Pediatr Crit Care Med2018; 19: S157–S162. DOI: 10.1097/PCC.0000000000001600.
KellyDPGrandinEWO’BrienKL. How we manage blood product support and coagulation in the adult patient requiring extracorporeal membrane oxygenation. Transfusion2022; 62: 741–750. DOI: 10.1111/trf.16830.
86.
DuarteCMLopesMIAbecasisF. Transfusion policy in pediatric extracorporeal membrane oxygenation patients: less could be more. Perfusion2024; 39: 96–105. DOI: 10.1177/02676591221105610.
87.
LiYXiongYWangR, et al.Blood banking-induced alteration of red blood cell oxygen release ability. Blood Transfus2016; 14: 238–244. DOI: 10.2450/2015.0055-15.
88.
KaniasTGladwinMT. Nitric oxide, hemolysis, and the red blood cell storage lesion: interactions between transfusion, donor, and recipient. Transfusion2012; 52: 1388–1392. DOI: 10.1111/j.1537-2995.2012.03748.x.
89.
HessJR. Red cell changes during storage. Transfus Apher Sci2010; 43: 51–59. DOI: 10.1016/j.transci.2010.05.009.
90.
McQuiltenZKFrenchCJNicholA, et al.Effect of age of red cells for transfusion on patient outcomes: a systematic review and meta-analysis. Transfus Med Rev2018; 32: 77–88. DOI: 10.1016/j.tmrv.2018.02.002.
91.
CooperDJMcQuiltenZKNicholA, et al.Age of red cells for transfusion and outcomes in critically ill adults. N Engl J Med2017; 377: 1858–1867. DOI: 10.1056/NEJMoa1707572.
92.
SpinellaPCTucciMFergussonDA, et al.Effect of fresh vs standard-issue red blood cell transfusions on multiple organ dysfunction syndrome in critically ill pediatric patients: a randomized clinical trial. JAMA2019; 322: 2179–2190. DOI: 10.1001/jama.2019.17478.
93.
ZimringJC. Fresh versus old blood: are there differences and do they matter?Hematology Am Soc Hematol Educ Program2013; 2013: 651–655. DOI: 10.1182/asheducation-2013.1.651.
94.
WalshTSJuffermansNP. New blood for old? High quality evidence that fresh red blood cells confer no benefit for critically ill patients. Intensive Care Med2018; 44: 506–508. DOI: 10.1007/s00134-018-5106-z.
95.
MacDonaldR. Red cell 2,3-diphosphoglycerate and oxygen affinity. Anaesthesia1977; 32: 544–553. DOI: 10.1111/j.1365-2044.1977.tb10002.x.
96.
GladwinMTOgnibeneFPPannellLK, et al.Relative role of heme nitrosylation and beta-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulation. Proc Natl Acad Sci U S A2000; 97: 9943–9948. DOI: 10.1073/pnas.180155397.
97.
ReynoldsJDHessDTStamlerJS. The transfusion problem: role of aberrant S-nitrosylation. Transfusion2011; 51: 852–858. DOI: 10.1111/j.1537-2995.2011.03097.x.
98.
GladwinMT. How red blood cells process nitric oxide: evidence for the nitrite hypothesis. Circulation2017; 135: 177–179. DOI: 10.1161/CIRCULATIONAHA.116.024752.
99.
SadakaFAggu-SherRKrauseK, et al.The effect of red blood cell transfusion on tissue oxygenation and microcirculation in severe septic patients. Ann Intensive Care2011; 1: 46. DOI: 10.1186/2110-5820-1-46.
100.
GarciaAVVelezAKSurmaV, et al.Impact of red blood cell transfusion on regional cerebral oxygen saturation during pediatric ECMO. Transfusion2023; 63: 942–951. DOI: 10.1111/trf.17317.
101.
LiuWHeHInceC, et al.The effect of blood transfusion on sublingual microcirculation in critically ill patients: a scoping review. Microcirculation2021; 28: e12666. DOI: 10.1111/micc.12666.
102.
WeinbergJAMacLennanPAVandromme-CusickMJ, et al.The deleterious effect of red blood cell storage on microvascular response to transfusion. J Trauma Acute Care Surg2013; 75: 807–812. DOI: 10.1097/TA.0b013e3182a74a9b.
103.
ZhangZYGaoDPYangJJ, et al.Impact of length of red blood cells transfusion on postoperative delirium in elderly patients undergoing hip fracture surgery: a cohort study. Injury2016; 47: 408–412. DOI: 10.1016/j.injury.2015.10.009.
104.
BrownCHGregaMSelnesOA, et al.Length of red cell unit storage and risk for delirium after cardiac surgery. Anesth Analg2014; 119: 242–250. DOI: 10.1213/ANE.0000000000000134.
105.
SaidASSpinellaPCHartmanME, et al.RBC distribution width: biomarker for red cell dysfunction and critical illness outcome?Pediatr Crit Care Med2017; 18: 134–142. DOI: 10.1097/PCC.0000000000001017.
106.
AlmacEInceC. The impact of storage on red cell function in blood transfusion. Best Pract Res Clin Anaesthesiol2007; 21: 195–208. DOI: 10.1016/j.bpa.2007.01.004.
107.
FortierNSnyderLMGarverF, et al.The relationship between in vivo generated hemoglobin skeletal protein complex and increased red cell membrane rigidity. Blood1988; 71: 1427–1431.
108.
LuSYOrtolevaJColonK, et al.Red blood cell distribution width predicts mortality of adult patients receiving veno-arterial extracorporeal membrane oxygenation. Perfusion2023. DOI: 10.1177/02676591231169850.
109.
JeneyVEatonJWBallaG, et al.Natural history of the bruise: formation, elimination, and biological effects of oxidized hemoglobin. Oxid Med Cell Longev2013; 2013: 703571. DOI: 10.1155/2013/703571.
110.
SmithAMcCullohRJ. Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders. Front Physiol2015; 6: 187. DOI: 10.3389/fphys.2015.00187.
111.
DoyleMPHoekstraJW. Oxidation of nitrogen oxides by bound dioxygen in hemoproteins. J Inorg Biochem1981; 14: 351–358. DOI: 10.1016/s0162-0134(00)80291-3.
112.
EichRFLiTLemonDD, et al.Mechanism of NO-induced oxidation of myoglobin and hemoglobin. Biochemistry1996; 35: 6976–6983. DOI: 10.1021/bi960442g.
113.
HodEASpitalnikSL. Stored red blood cell transfusions: iron, inflammation, immunity, and infection. Transfus Clin Biol2012; 19: 84–89. DOI: 10.1016/j.tracli.2012.04.001.
114.
DaherRKarimZ. Iron metabolism: state of the art. Transfus Clin Biol2017; 24: 115–119. DOI: 10.1016/j.tracli.2017.06.015.
115.
McDowellLAKudaravalliPSticcoKL. Iron overload. StatPearls. Treasure. Island (FL), 2023.
116.
GanzT. Iron and infection. Int J Hematol2018; 107: 7–15. DOI: 10.1007/s12185-017-2366-2.
117.
EllermannMArthurJC. Siderophore-mediated iron acquisition and modulation of host-bacterial interactions. Free Radic Biol Med2017; 105: 68–78. DOI: 10.1016/j.freeradbiomed.2016.10.489.
118.
NealMDRavalJSTriulziDJ, et al.Innate immune activation after transfusion of stored red blood cells. Transfus Med Rev2013; 27: 113–118. DOI: 10.1016/j.tmrv.2013.01.001.
119.
GaoYLvLLiuS, et al.Elevated levels of thrombin-generating microparticles in stored red blood cells. Vox Sang2013; 105: 11–17. DOI: 10.1111/vox.12014.
120.
RubinODelobelJPrudentM, et al.Red blood cell-derived microparticles isolated from blood units initiate and propagate thrombin generation. Transfusion2013; 53: 1744–1754. DOI: 10.1111/trf.12008.
121.
Abdalkream JawishTAHessenHMAlshafeeaMA, et al.Red cell alloimmunization in repeatedly transfused Sudanese patients with leukemia in northern Sudan. Asian Pac J Cancer Prev APJCP2023; 24: 21–24. DOI: 10.31557/APJCP.2023.24.1.21.
122.
PirenneFPondarreC. Alloimmunization and hyperhemolysis in sickle cell disease. Hematology Am Soc Hematol Educ Program2023; 2023: 653–659. DOI: 10.1182/hematology.2023000499.
123.
AlmorishMAWAl-AbsiBElkhalifaAME, et al.Red blood cell alloimmunization in blood transfusion-dependent beta thalassemia major patients in Sana'a City-Yemen. Sci Rep2024; 14: 1005. DOI: 10.1038/s41598-024-51561-2.
124.
SanzCNomdedeuMBelkaidM, et al.Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia. Transfusion2013; 53: 710–715. DOI: 10.1111/j.1537-2995.2012.03819.x.
125.
BhuvaDKVachhaniJH. Red cell alloimmunization in repeatedly transfused patients. Asian J Transfus Sci2017; 11: 115–120. DOI: 10.4103/0973-6247.214347.
126.
TormeyCAHendricksonJE. Transfusion-related red blood cell alloantibodies: induction and consequences. Blood2019; 133: 1821–1830. DOI: 10.1182/blood-2018-08-833962.
127.
ChadebechPHabibiANzouakouR, et al.Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death. Transfusion2009; 49: 1785–1792. DOI: 10.1111/j.1537-2995.2009.02199.x.
128.
SuddockJTCrookstonKP. Transfusion reactions. StatPearls. Treasure Island (FL), 2023.
MarchioriEHochheggerBZanettiG. Transfusion-related acute lung injury: an uncommon cause of pulmonary edema. J Bras Pneumol2023; 49: e20230175–20230821. DOI: 10.36416/1806-3756/e20230175.
131.
SillimanCCBoshkovLKMehdizadehkashiZ, et al.Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood2003; 101: 454–462. DOI: 10.1182/blood-2002-03-0958.
132.
ReynoldsJDBennettKMCinaAJ, et al.S-nitrosylation therapy to improve oxygen delivery of banked blood. Proc Natl Acad Sci U S A2013; 110: 11529–11534. DOI: 10.1073/pnas.1306489110.
133.
Bor-KucukatayMWenbyRBMeiselmanHJ, et al.Effects of nitric oxide on red blood cell deformability. Am J Physiol Heart Circ Physiol2003; 284: H1577–1584. DOI: 10.1152/ajpheart.00665.2002.
134.
FriederichJAButterworthJFT. Sodium nitroprusside: twenty years and counting. Anesth Analg1995; 81: 152–162. DOI: 10.1097/00000539-199507000-00031.
135.
HottingerDGBeebeDSKozhimannilT, et al.Sodium nitroprusside in 2014: a clinical concepts review. J Anaesthesiol Clin Pharmacol2014; 30: 462–471. DOI: 10.4103/0970-9185.142799.
136.
HammerGBLewandowskiADroverDR, et al.Safety and efficacy of sodium nitroprusside during prolonged infusion in pediatric patients. Pediatr Crit Care Med2015; 16: 397–403. DOI: 10.1097/PCC.0000000000000383.
137.
MorrisAAPageRL2ndBaumgartnerLJ, et al.Thiocyanate accumulation in critically ill patients receiving nitroprusside infusions. J Intensive Care Med2017; 32: 547–553. DOI: 10.1177/0885066616657004.
138.
HallVAGuestJM. Sodium nitroprusside-induced cyanide intoxication and prevention with sodium thiosulfate prophylaxis. Am J Crit Care1992; 1: 19–25, quiz 26-17.
139.
IvankovichADBravermanBStephensTS, et al.Sodium thiosulfate disposition in humans: relation to sodium nitroprusside toxicity. Anesthesiology1983; 58: 11–17. DOI: 10.1097/00000542-198301000-00003.
140.
IvankovichADBravermanBShulmanM, et al.Prevention of nitroprusside toxicity with thiosulfate in dogs. Anesth Analg1982; 61: 120–126.
141.
Al-Sa’DoniHFerroAS-Nitrosothiols. A class of nitric oxide-donor drugs. Clin Sci2000; 98. DOI: 10.1042/cs0980507.
142.
MassaCMLiuZTaylorS, et al.Biological mechanisms of S-nitrosothiol formation and degradation: how is specificity of S-nitrosylation achieved?Antioxidants2021; 10: 1111. DOI: 10.3390/antiox10071111.
143.
JaworskiKKinardFGoldsteinD, et al.S-nitrosothiols do not induce oxidative stress, contrary to other nitric oxide donors, in cultures of vascular endothelial or smooth muscle cells. Eur J Pharmacol2001; 425: 11–19. DOI: 10.1016/s0014-2999(01)01166-9.
144.
EwingJFYoungDVJaneroDR, et al.Nitrosylated bovine serum albumin derivatives as pharmacologically active nitric oxide congeners. J Pharmacol Exp Therapeut1997; 283: 947–954.
145.
ForstermannUMunzelT. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation2006; 113: 1708–1714. DOI: 10.1161/CIRCULATIONAHA.105.602532.
146.
RoyRWilcoxJWebbAJ, et al.Dysfunctional and dysregulated nitric oxide synthases in cardiovascular disease: mechanisms and therapeutic potential. Int J Mol Sci2023: 24: 15200. DOI: 10.3390/ijms242015200.
147.
BucciMRoviezzoFPosadasI, et al.Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo. Proc Natl Acad Sci USA2005; 102: 904–908. DOI: 10.1073/pnas.0408906102.
148.
O'MearaCTimpaJPeekG, et al.Nitric oxide on extracorporeal life support-circuit modifications for a safe therapy. J Extra Corpor Technol2022; 54: 142–147. DOI: 10.1182/ject-142-147.
149.
BennettMThuysCAugustinS, et al.The safe addition of nitric oxide into the sweep gas of the extracorporeal circuit during cardiopulmonary bypass and extracorporeal life support. J Extra Corpor Technol2018; 50: 260–264.
150.
ChilettiRHortonSBednarzA, et al.Safety of nitric oxide added to the ECMO circuit: a pilot study in children. Perfusion2018; 33: 74–76. DOI: 10.1177/0267659117720495.
151.
RossidisACLawrenceKMMejaddamAY, et al.The effects of nitric oxide in oxygenator sweep gas during extracorporeal circulation in a neonatal ovine model. Am Soc Artif Intern Organs J2020; 66: 671–676. DOI: 10.1097/MAT.0000000000001047.
152.
LinardiDManiRMartinazziS, et al.Abstract 109: nitric oxide added to the EMCO circuit improves neuroprotection and cardiac function after cardiac arrest. Resuscitation science symposium2023; 148: 109. Circulation, 2023.
153.
TorokJABrahmajothiMVZhuH, et al.Transpulmonary flux of S-nitrosothiols and pulmonary vasodilation during nitric oxide inhalation: role of transport. Am J Respir Cell Mol Biol2012; 47: 37–43. DOI: 10.1165/rcmb.2011-0439OC.
154.
NgESJourd'heuilDMcCordJM, et al.Enhanced S-nitroso-albumin formation from inhaled NO during ischemia/reperfusion. Circ Res2004; 94: 559–565. DOI: 10.1161/01.RES.0000117771.63140.D6.
155.
HamanakaSTanemotoKInagakiE, et al.Direct measurement of nitric oxide during experimental cardiopulmonary bypass. J Int Med Res2005; 33: 295–300. DOI: 10.1177/147323000503300304.
156.
RiveraBKNaiduSKSubramanianK, et al.Real-time, in vivo determination of dynamic changes in lung and heart tissue oxygenation using EPR oximetry. Adv Exp Med Biol2014; 812: 81–86. DOI: 10.1007/978-1-4939-0620-8_11.
